Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy.

Date publication

janvier 2007

Auteurs

Membres identifiés du Cancéropôle Est :
Pr PETIT Thierry , Dr QUETIN Philippe , Pr VELTEN Michel

Tous les auteurs :
Petit T, Velten M, d'Hombres A, Marchal C, Montbarbon X, Mornex F, Quetin P, Gerard JP, Romestaing P, Carrie C

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/16987544

Résumé

OBJECTIVE: Attempts to increase survival in stage III ovarian cancer patients with minimal residual disease at second-look laparotomy have included consolidation radiotherapy. We present long-term survival of 106 consecutive patients treated between 1983 and 1993 in 4 French institutions for stage III ovarian adenocarcinoma with first-look debulking, cisplatin-based chemotherapy, second-look surgery with a residual disease

Référence

Gynecol Oncol. 2007 Jan;104(1):104-8